Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.
前收盤價
US$70.57
−US$0.12 · -0.17%
盤中時間採用ET。市場資料可能有所延遲。
Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.
日內區間
目前US$70.57
52週區間
目前US$70.57
盤中時間採用ET。市場資料可能有所延遲。
Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.
日內區間
目前US$70.57
52週區間
目前US$70.57
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 18.24億 USD | 21.13億 USD | 21.91億 USD | 23.91億 USD | 21.11億 USD |
| 銷貨成本 | 12.75億 USD | 14.95億 USD | 15.23億 USD | 15.61億 USD | 14.41億 USD |
| 毛利 | 5.49億 USD | 6.18億 USD | 6.68億 USD | 8.3億 USD | 6.7億 USD |
| 研究與開發 | 5400萬 USD | 5500萬 USD | 5100萬 USD | 5500萬 USD | 5000萬 USD |
| 銷售、一般及管理費用 | 3.45億 USD | 4.04億 USD | 3.65億 USD | 3.93億 USD | 3.58億 USD |
| 營業費用 | 13.24億 USD | 6.44億 USD | 4.96億 USD | 4.97億 USD | 4.78億 USD |
| 利息收入 | 500萬 USD | 1000萬 USD | 1200萬 USD | 400萬 USD | 100萬 USD |
| 利息支出 | 6300萬 USD | 5300萬 USD | 5700萬 USD | 6600萬 USD | 7300萬 USD |
| 折舊和攤銷 | 2.37億 USD | 2.74億 USD | 2.43億 USD | 2.41億 USD | 2.44億 USD |
| 營業利益 | −7.75億 USD | −2600萬 USD | 1.72億 USD | 3.33億 USD | 1.92億 USD |
| 淨利 | −8.45億 USD | 1.69億 USD | 1.78億 USD | 9.27億 USD | 2.2億 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI1.07億0.00%2.3兆 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM8634.35萬0.11%787.4億 USD0.19%US$278.94+0.49%
Vanguard Morningstar Small-Cap ETFVB7721.9萬0.04%1853億 USD0.03%US$289.48+0.64%
Avantis U.S. Small Cap Value ETFAVUV6586.48萬0.21%308.51億 USD0.25%US$119.64-0.41%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV6044.62萬0.22%268.09億 USD0.33%US$37.95-0.39%
Vanguard Morningstar Small-Cap Value ETFVBR4906.23萬0.07%682億 USD0.05%US$234.43+0.22%
Vanguard Extended Market ETFVXF3902.42萬0.04%954億 USD0.05%US$235+0.80%
Dimensional - US Targeted Value ETFDFAT3878.89萬0.13%301.22億 USD0.33%US$67.27-0.43%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Morningstar Small-Cap ETFVB
Avantis U.S. Small Cap Value ETFAVUV
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Morningstar Small-Cap Value ETFVBR
Vanguard Extended Market ETFVXF
Dimensional - US Targeted Value ETFDFATAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。